De-Escalation Strategies for Human Papillomavirus-Associated Oropharyngeal Squamous Cell Carcinoma-Where Are We Now?

被引:15
作者
Silver, Jennifer A. [1 ,2 ]
Turkdogan, Sena [1 ,2 ]
Roy, Catherine F. [1 ,2 ]
Subramaniam, Thavakumar [1 ,2 ]
Henry, Melissa [2 ,3 ,4 ,5 ]
Sadeghi, Nader [1 ,2 ,6 ]
机构
[1] McGill Univ Hlth Ctr, Dept Otolaryngol Head & Neck Surg, Montreal, PQ H4A 3JI, Canada
[2] McGill Univ, Dept Otolaryngol Head & Neck Surg, Montreal, PQ H4A 3JI, Canada
[3] McGill Univ, Gerald Bronfman Dept Oncol, Montreal, PQ H4A 3JI, Canada
[4] Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada
[5] Jewish Gen Hosp, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada
[6] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ H4A 3JI, Canada
关键词
oropharyngeal squamous cell carcinoma; human papillomavirus; de-escalation; transoral surgery; TRANSORAL ROBOTIC SURGERY; LOCALLY ADVANCED HEAD; INDUCTION CHEMOTHERAPY; RANDOMIZED-TRIAL; NECK-CANCER; FUNCTIONAL OUTCOMES; RADIATION-THERAPY; SALIVARY-GLANDS; POSITIVE HEAD; RADIOTHERAPY;
D O I
10.3390/curroncol29050295
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prevalence of oropharyngeal squamous cell carcinoma has been increasing in North America due to human papillomavirus-associated disease. It is molecularly distinct and differs from other head and neck cancers due to the young population and high survival rate. The treatment regimens currently in place cause significant long-term toxicities. Studies have transitioned from mortality-based outcomes to patient-reported outcomes assessing quality of life. There are many completed and ongoing trials investigating alternative therapy regimens or de-escalation strategies to minimize the negative secondary effects while maintaining overall survival and disease-free survival. The goal of this review is to discuss the most recent advancements within the field while summarizing and reviewing the available evidence.
引用
收藏
页码:3668 / 3697
页数:30
相关论文
共 79 条
[31]  
GOEPFERT H, 1979, LARYNGOSCOPE, V89, P315
[32]   Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma [J].
Gupta, Tejpal ;
Kannan, Sadhana ;
Ghosh-Laskar, Sarbani ;
Agarwal, Jai Prakash .
PLOS ONE, 2018, 13 (07)
[33]   Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial [J].
Haddad, Robert ;
O'Neill, Anne ;
Rabinowits, Guilherme ;
Tishler, Roy ;
Khuri, Fadlo ;
Adkins, Douglas ;
Clark, Joseph ;
Sarlis, Nicholas ;
Lorch, Jochen ;
Beitler, Jonathan J. ;
Limaye, Sewanti ;
Riley, Sarah ;
Posner, Marshall .
LANCET ONCOLOGY, 2013, 14 (03) :257-264
[34]   Comparison of Carboplatin With 5-Fluorouracil vs. Cisplatin as Concomitant Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma [J].
Hanemaaijer, Saskia H. ;
Kok, Iris C. ;
Fehrmann, Rudolf S. N. ;
van der Vegt, Bert ;
Gietema, Jourik A. ;
Plaat, Boudewijn E. C. ;
van Vugt, Marcel A. T. M. ;
Vergeer, Marije R. ;
Leemans, C. Rene ;
Langendijk, Johannes A. ;
Voortman, Jens ;
Buter, Jan ;
Oosting, Sjoukje F. .
FRONTIERS IN ONCOLOGY, 2020, 10
[35]   Postoperative Chemoradiotherapy and Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck: Radiation Therapy Oncology Group RTOG-0234 [J].
Harari, Paul M. ;
Harris, Jonathan ;
Kies, Merrill S. ;
Myers, Jeffrey N. ;
Jordan, Richard C. ;
Gillison, Maura L. ;
Foote, Robert L. ;
Machtay, Mitchell ;
Rotman, Marvin ;
Khuntia, Deepak ;
Straube, William ;
Zhang, Qiang ;
Ang, Kian .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (23) :2486-U290
[36]   Implementation of human papillomavirus circulating tumor DNA to identify recurrence during treatment de-escalation [J].
Haring, Catherine T. ;
Brummel, Collin ;
Bhambhani, Chandan ;
Jewell, Brittany ;
Neal, Molly Heft ;
Bhangale, Apurva ;
Casper, Keith ;
Malloy, Kelly ;
McLean, Scott ;
Shuman, Andrew ;
Stucken, Chaz ;
Rosko, Andrew ;
Prince, Mark ;
Bradford, Carol ;
Eisbruch, Avraham ;
Mierzwa, Michelle ;
Tewari, Muneesh ;
Worden, Francis P. ;
Swiecicki, Paul L. ;
Spector, Matthew E. ;
Brenner, J. Chad .
ORAL ONCOLOGY, 2021, 121
[37]   TRANSORAL LASER MICROSURGERY AS PRIMARY TREATMENT FOR ADVANCED-STAGE OROPHARYNGEAL CANCER: A UNITED STATES MULTICENTER STUDY [J].
Haughey, Bruce H. ;
Hinni, Michael L. ;
Salassa, John R. ;
Hayden, Richard E. ;
Grant, David G. ;
Rich, Jason T. ;
Milov, Simon ;
Lewis, James S., Jr. ;
Krishna, Murli .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2011, 33 (12) :1683-1694
[38]   Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer [J].
Huang, Shao Hui ;
Perez-Ordonez, Bayardo ;
Weinreb, Ilan ;
Hope, Andrew ;
Massey, Christine ;
Waldron, John N. ;
Kim, John ;
Bayley, Andrew J. ;
Cummings, Bernard ;
Cho, B. C. John ;
Ringash, Jolie ;
Dawson, Laura A. ;
Siu, Lillian L. ;
Chen, Eric ;
Irish, Jonathan ;
Gullane, Patrick ;
Hui, Angela ;
Liu, Fei-Fei ;
Shen, Xiaowei ;
Xu, Wei ;
O'Sullivan, Brian .
ORAL ONCOLOGY, 2013, 49 (01) :79-85
[39]   Therapeutic strategies for systemic therapies of human papillomavirus-related oropharyngeal cancer [J].
Hung, Tony K. W. ;
Ho, Alan L. ;
Pfister, David G. .
JOURNAL OF SURGICAL ONCOLOGY, 2021, 124 (06) :952-961
[40]   Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: Single-institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma [J].
Loerincz, Balazs B. ;
Moeckelmann, Nikolaus ;
Busch, Chia-Jung ;
Knecht, Rainald .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2015, 37 (11) :1618-1624